Annexin Pharmaceuticals (Sweden) Analysis
| ANNX Stock | SEK 0.54 0.06 12.50% |
Annexin Pharmaceuticals AB is overvalued with Real Value of 0.45 and Hype Value of 0.54. The main objective of Annexin Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Annexin Pharmaceuticals AB is worth, separate from its market price. There are two main types of Annexin Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Annexin Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Annexin Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Annexin Pharmaceuticals stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Annexin Pharmaceuticals is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Annexin Stock trading window is adjusted to Europe/Stockholm timezone.
Annexin |
Annexin Stock Analysis Notes
About 45.0% of the company shares are held by company insiders. The book value of Annexin Pharmaceuticals was presently reported as 0.2. The company recorded a loss per share of 0.43. Annexin Pharmaceuticals had not issued any dividends in recent years. Annexin Pharmaceuticals AB , a biotechnology company, engages in developing drug candidates for the treatment of various cardiovascular diseases. The company was founded in 2014 and is based in Stockholm, Sweden. Annexin Pharmaceuticals is traded on Stockholm Stock Exchange in Sweden. For more info on Annexin Pharmaceuticals AB please contact the company at 46 7 09 65 16 65 or go to https://www.annexinpharma.com/sv.Annexin Pharmaceuticals Investment Alerts
| Annexin Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Annexin Pharmaceuticals had very high historical volatility over the last 90 days | |
| Annexin Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (52.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Annexin Pharmaceuticals AB has accumulated about 22.77 M in cash with (45.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 45.0% of the company shares are held by company insiders |
Annexin Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 189.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Annexin Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Annexin Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of November, Annexin Pharmaceuticals shows the Standard Deviation of 4.66, mean deviation of 3.49, and Risk Adjusted Performance of (0.03). Annexin Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Annexin Pharmaceuticals Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Annexin Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Annexin Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Annexin Pharmaceuticals Outstanding Bonds
Annexin Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Annexin Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Annexin bonds can be classified according to their maturity, which is the date when Annexin Pharmaceuticals AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Annexin Pharmaceuticals Predictive Daily Indicators
Annexin Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Annexin Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 12942.11 | |||
| Daily Balance Of Power | 1.0 | |||
| Rate Of Daily Change | 1.13 | |||
| Day Median Price | 0.52 | |||
| Day Typical Price | 0.53 | |||
| Price Action Indicator | 0.05 | |||
| Period Momentum Indicator | 0.06 |
Annexin Pharmaceuticals Forecast Models
Annexin Pharmaceuticals' time-series forecasting models are one of many Annexin Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Annexin Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Annexin Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Annexin Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Annexin shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Annexin Pharmaceuticals. By using and applying Annexin Stock analysis, traders can create a robust methodology for identifying Annexin entry and exit points for their positions.
Annexin Pharmaceuticals AB , a biotechnology company, engages in developing drug candidates for the treatment of various cardiovascular diseases. The company was founded in 2014 and is based in Stockholm, Sweden. Annexin Pharmaceuticals is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Annexin Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Additional Tools for Annexin Stock Analysis
When running Annexin Pharmaceuticals' price analysis, check to measure Annexin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexin Pharmaceuticals is operating at the current time. Most of Annexin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Annexin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Annexin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.